This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.


This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Elisabetta Bugianesi
Division of Gastroenterology, Department of Medical Sciences, University of Torino, Torino, Italy

Prof. Bugianesi is a clinician and scientist, internationally acknowledged expert on Non-Alcoholic Fatty Liver Disease (NAFLD/NASH) with 20 years of experience in the field. Her clinical practice is based in the Division of Gastroenterology at the AOU Città della Scienza e della Salute di Torino. She leads the regional NAFLD specialist clinical service based at the San Giovanni Antica Sede Hospital, in Torino. She has made a particular impact with work describing the metabolic mechanisms related to the onset and progression of liver damage and its links with the metabolic syndrome and its components, the natural history of the disease, including the first demonstration of HCC as a complication, the development of non-invasive markers of fibrosis and the involvement in several trials for the treatment of NAFLD.  Her post-graduate training included a PhD fellowship in Hepatology at Case Western Reserve University in USA, where she became expert in the use of stable isotopes to study in vivo metabolism.